Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Riwes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Hematology|July 22, 2020
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitisMary Riwes, Pavan Reddy
Blood|August 9, 2017
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCTSung Won Choi, Thomas Braun, Israel Henig, et al.
Blood Advances|October 4, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantationJohn M Magenau, Dan Peltier, Mary Riwes, et al.
Scientific Reports|August 22, 2018
Murine Models of Steroid Refractory Graft-versus-Host DiseaseTomomi Toubai, Corinne Rossi, Isao Tawara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2019
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic TransplantationJohn Magenau, Thomas Braun, Erin Gatza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Blood Advances|January 4, 2018
IAPs protect host target tissues from graft-versus-host disease in miceTomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Nature Microbiology|March 13, 2019
Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial compositionTomomi Toubai, Hideaki Fujiwara, Corinne Rossi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Hematology|July 22, 2020
Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitisMary Riwes, Pavan Reddy
Blood|August 9, 2017
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCTSung Won Choi, Thomas Braun, Israel Henig, et al.
Blood Advances|October 4, 2021
Type 1 interferon to prevent leukemia relapse after allogeneic transplantationJohn M Magenau, Dan Peltier, Mary Riwes, et al.
Scientific Reports|August 22, 2018
Murine Models of Steroid Refractory Graft-versus-Host DiseaseTomomi Toubai, Corinne Rossi, Isao Tawara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2019
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple MyelomaAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2019
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic TransplantationJohn Magenau, Thomas Braun, Erin Gatza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2016
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host DiseaseHolly K Miller, Thomas M Braun, Terri Stillwell, et al.
Blood Advances|January 4, 2018
IAPs protect host target tissues from graft-versus-host disease in miceTomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, et al.
Bone Marrow Transplantation|July 21, 2015
FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AMLYeohan Song, John Magenau, Yumeng Li, et al.
Nature Microbiology|March 13, 2019
Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial compositionTomomi Toubai, Hideaki Fujiwara, Corinne Rossi, et al.
Pageof 2